This information is intended for Connecticut Prescribers
HB 6669
Diabetes Products
Last Update: January 3, 2024
Vaccines
Last Update: July 19, 2024
ALDURAZYME® (laronidase)
Last Update: January 5, 2024
ALPROLIX® [Coagulation factor IX (recombinant), Fc fusion protein]
Last Update: January 3, 2024
ALTUVIIIO® [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl]
Last Update: January 3, 2024
CABLIVI® (caplacizumab-yhdp)
Last Update: January 3, 2024
CERDELGA® (eliglustat) capsules, for oral use
Last Update: January 5, 2024
Cerezyme® (imiglucerase) for injection
Last Update: September 18, 2022
DUPIXENT® (dupilumab) Injection
Last Update: January 3, 2024
ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein]
Last Update: January 3, 2024
ENJAYMO® (sutimlimab-jome) injection, for intravenous use
Last Update: January 3, 2024
FABRAZYME® (agalsidase beta) for injection, for intravenous use
Last Update: January 5, 2024
Jevtana® (cabazitaxel) injection
Last Update: July 1, 2024
KEVZARA® (sarilumab)
Last Update: January 3, 2024
LEMTRADA® (alemtuzumab)
Last Update: July 1, 2024
LUMIZYME® (alglucosidase alfa)
Last Update: January 5, 2024
MULTAQ® (dronedarone)
Last Update: January 3, 2024
NEXVIAZYME® (avalglucosidase alfa-ngpt) for injection, for intravenous use
Last Update: January 5, 2024
REZUROCK® (belumosudil) tablets
Last Update: January 3, 2024
SARCLISA® (isatuximab-irfc) injection
Last Update: July 1, 2024
Thymoglobulin® [Anti-thymocyte Globulin (Rabbit)]
Last Update: January 3, 2024
THYROGEN® (thyrotropin alfa for injection)
Last Update: January 15, 2024
TZIELD® (teplizumab-mzwv)
Last Update: July 1, 2024
XENPOZYME® (olipudase alfa-rpcp) for injection, for intravenous use
Last Update: January 5, 2024
House Bill 6669. Published by the General Assembly of the State of Connecticut
Please See Full Prescribing Information, including Boxed Warning, for Aldurazyme, Cerezyme, Fabrazyme, Jevtana, Kevzara, Lemtrada, Lumizyme, Multaq, Nexviazyme, Thymoglobulin , Xenpozyme
MAT-US-2308341-v3.0-08/2024